Skip to main content
. Author manuscript; available in PMC: 2015 Jan 13.
Published in final edited form as: Invest New Drugs. 2014 Mar 27;32(4):739–745. doi: 10.1007/s10637-014-0083-8

Table 4.

Response to RO4929097 Treatment

Variable Evaluable Patients (N = 12)


Response
    Stable Disease N (%) 3 (25)
    Progression 9 (75)

Note: 6 patients were not evaluable for response.